The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ligand Binding Assay Market Research Report 2025
Synopsis
Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.
The global Ligand Binding Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ligand Binding Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ligand Binding Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ligand Binding Assay in Biomedical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ligand Binding Assay include Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ligand Binding Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ligand Binding Assay.
Report Scope
The Ligand Binding Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ligand Binding Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ligand Binding Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc
Segment by Type
Radioactive
Non-radioactive
Segment by Application
Biomedical Research
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ligand Binding Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.
The global Ligand Binding Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ligand Binding Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ligand Binding Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ligand Binding Assay in Biomedical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ligand Binding Assay include Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ligand Binding Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ligand Binding Assay.
Report Scope
The Ligand Binding Assay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ligand Binding Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ligand Binding Assay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc
Segment by Type
Radioactive
Non-radioactive
Segment by Application
Biomedical Research
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ligand Binding Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ligand Binding Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radioactive
1.2.3 Non-radioactive
1.3 Market by Application
1.3.1 Global Ligand Binding Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biomedical Research
1.3.3 Drug Discovery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ligand Binding Assay Market Perspective (2019-2030)
2.2 Ligand Binding Assay Growth Trends by Region
2.2.1 Global Ligand Binding Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ligand Binding Assay Historic Market Size by Region (2019-2024)
2.2.3 Ligand Binding Assay Forecasted Market Size by Region (2025-2030)
2.3 Ligand Binding Assay Market Dynamics
2.3.1 Ligand Binding Assay Industry Trends
2.3.2 Ligand Binding Assay Market Drivers
2.3.3 Ligand Binding Assay Market Challenges
2.3.4 Ligand Binding Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ligand Binding Assay Players by Revenue
3.1.1 Global Top Ligand Binding Assay Players by Revenue (2019-2024)
3.1.2 Global Ligand Binding Assay Revenue Market Share by Players (2019-2024)
3.2 Global Ligand Binding Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ligand Binding Assay Revenue
3.4 Global Ligand Binding Assay Market Concentration Ratio
3.4.1 Global Ligand Binding Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ligand Binding Assay Revenue in 2023
3.5 Ligand Binding Assay Key Players Head office and Area Served
3.6 Key Players Ligand Binding Assay Product Solution and Service
3.7 Date of Enter into Ligand Binding Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ligand Binding Assay Breakdown Data by Type
4.1 Global Ligand Binding Assay Historic Market Size by Type (2019-2024)
4.2 Global Ligand Binding Assay Forecasted Market Size by Type (2025-2030)
5 Ligand Binding Assay Breakdown Data by Application
5.1 Global Ligand Binding Assay Historic Market Size by Application (2019-2024)
5.2 Global Ligand Binding Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ligand Binding Assay Market Size (2019-2030)
6.2 North America Ligand Binding Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ligand Binding Assay Market Size by Country (2019-2024)
6.4 North America Ligand Binding Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ligand Binding Assay Market Size (2019-2030)
7.2 Europe Ligand Binding Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ligand Binding Assay Market Size by Country (2019-2024)
7.4 Europe Ligand Binding Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ligand Binding Assay Market Size (2019-2030)
8.2 Asia-Pacific Ligand Binding Assay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ligand Binding Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific Ligand Binding Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ligand Binding Assay Market Size (2019-2030)
9.2 Latin America Ligand Binding Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ligand Binding Assay Market Size by Country (2019-2024)
9.4 Latin America Ligand Binding Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ligand Binding Assay Market Size (2019-2030)
10.2 Middle East & Africa Ligand Binding Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ligand Binding Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa Ligand Binding Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sygnature Discovery
11.1.1 Sygnature Discovery Company Detail
11.1.2 Sygnature Discovery Business Overview
11.1.3 Sygnature Discovery Ligand Binding Assay Introduction
11.1.4 Sygnature Discovery Revenue in Ligand Binding Assay Business (2019-2024)
11.1.5 Sygnature Discovery Recent Development
11.2 Shanghai Medicilon Inc
11.2.1 Shanghai Medicilon Inc Company Detail
11.2.2 Shanghai Medicilon Inc Business Overview
11.2.3 Shanghai Medicilon Inc Ligand Binding Assay Introduction
11.2.4 Shanghai Medicilon Inc Revenue in Ligand Binding Assay Business (2019-2024)
11.2.5 Shanghai Medicilon Inc Recent Development
11.3 Intertek Group plc
11.3.1 Intertek Group plc Company Detail
11.3.2 Intertek Group plc Business Overview
11.3.3 Intertek Group plc Ligand Binding Assay Introduction
11.3.4 Intertek Group plc Revenue in Ligand Binding Assay Business (2019-2024)
11.3.5 Intertek Group plc Recent Development
11.4 PerkinElmer Inc
11.4.1 PerkinElmer Inc Company Detail
11.4.2 PerkinElmer Inc Business Overview
11.4.3 PerkinElmer Inc Ligand Binding Assay Introduction
11.4.4 PerkinElmer Inc Revenue in Ligand Binding Assay Business (2019-2024)
11.4.5 PerkinElmer Inc Recent Development
11.5 Charles River
11.5.1 Charles River Company Detail
11.5.2 Charles River Business Overview
11.5.3 Charles River Ligand Binding Assay Introduction
11.5.4 Charles River Revenue in Ligand Binding Assay Business (2019-2024)
11.5.5 Charles River Recent Development
11.6 Alliance Pharma
11.6.1 Alliance Pharma Company Detail
11.6.2 Alliance Pharma Business Overview
11.6.3 Alliance Pharma Ligand Binding Assay Introduction
11.6.4 Alliance Pharma Revenue in Ligand Binding Assay Business (2019-2024)
11.6.5 Alliance Pharma Recent Development
11.7 Eurofins Discovery
11.7.1 Eurofins Discovery Company Detail
11.7.2 Eurofins Discovery Business Overview
11.7.3 Eurofins Discovery Ligand Binding Assay Introduction
11.7.4 Eurofins Discovery Revenue in Ligand Binding Assay Business (2019-2024)
11.7.5 Eurofins Discovery Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Detail
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Ligand Binding Assay Introduction
11.8.4 Creative Biogene Revenue in Ligand Binding Assay Business (2019-2024)
11.8.5 Creative Biogene Recent Development
11.9 IBR Inc
11.9.1 IBR Inc Company Detail
11.9.2 IBR Inc Business Overview
11.9.3 IBR Inc Ligand Binding Assay Introduction
11.9.4 IBR Inc Revenue in Ligand Binding Assay Business (2019-2024)
11.9.5 IBR Inc Recent Development
11.10 LGC Limited
11.10.1 LGC Limited Company Detail
11.10.2 LGC Limited Business Overview
11.10.3 LGC Limited Ligand Binding Assay Introduction
11.10.4 LGC Limited Revenue in Ligand Binding Assay Business (2019-2024)
11.10.5 LGC Limited Recent Development
11.11 Accelero Bioanalytics GmbH
11.11.1 Accelero Bioanalytics GmbH Company Detail
11.11.2 Accelero Bioanalytics GmbH Business Overview
11.11.3 Accelero Bioanalytics GmbH Ligand Binding Assay Introduction
11.11.4 Accelero Bioanalytics GmbH Revenue in Ligand Binding Assay Business (2019-2024)
11.11.5 Accelero Bioanalytics GmbH Recent Development
11.12 Gifford Bioscience Limited
11.12.1 Gifford Bioscience Limited Company Detail
11.12.2 Gifford Bioscience Limited Business Overview
11.12.3 Gifford Bioscience Limited Ligand Binding Assay Introduction
11.12.4 Gifford Bioscience Limited Revenue in Ligand Binding Assay Business (2019-2024)
11.12.5 Gifford Bioscience Limited Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Detail
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Ligand Binding Assay Introduction
11.13.4 GE Healthcare Revenue in Ligand Binding Assay Business (2019-2024)
11.13.5 GE Healthcare Recent Development
11.14 Antigen Discovery Inc
11.14.1 Antigen Discovery Inc Company Detail
11.14.2 Antigen Discovery Inc Business Overview
11.14.3 Antigen Discovery Inc Ligand Binding Assay Introduction
11.14.4 Antigen Discovery Inc Revenue in Ligand Binding Assay Business (2019-2024)
11.14.5 Antigen Discovery Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
